English | Español
Patient Daily | Apr 10, 2026

FDA approves high-dose Spinraza for spinal muscular atrophy treatment
Patient Daily | Apr 10, 2026

AbbVie maintains confidence in Skyrizi after FDA approval of Icotyde for plaque psoriasis
Patient Daily | Apr 10, 2026

Takeda restructuring could affect more than 600 US employees, company says
Patient Daily | Apr 10, 2026

Lilly and Baseline investigate GLP-1 drugs for substance use disorders as research grows
Patient Daily | Apr 10, 2026

Kardigan blood pressure drug advances after mixed Phase 2 trial results
Patient Daily | Apr 10, 2026

FDA expected to make key drug approval decisions in second quarter of 2026
Patient Daily | Apr 10, 2026

Kevin Tang returns as Aurinia CEO with $50 million offer for Kezar Life Sciences
Patient Daily | Apr 10, 2026

Study shows PSMA therapy can delay hormone treatment in prostate cancer patients

Trending
+ Pharmaceuticals
Patient Daily | Apr 23, 2026

Bristol Myers Squibb spinout Beeline Medicines launches with $300 million and five assets
Patient Daily | Apr 23, 2026

Taxpayers Protection Alliance director says 340B program raises costs for patients and taxpayers
Patient Daily | Apr 23, 2026

Health policy advocate raises concerns about 340B program's impact on patients
+ Pharmaceuticals
Patient Daily | Apr 20, 2026

FDA reviews safety of abortion pill mifepristone after court ruling on mail access